CN Stock MarketDetailed Quotes

600436 Zhangzhou Pientzehuang Pharmaceutical

Watchlist
  • 237.49
  • -0.13-0.05%
Not Open May 21 15:00 CST
143.28BMarket Cap47.73P/E (TTM)

Zhangzhou Pientzehuang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-20.05%2.37B
-53.58%1.16B
8.98%2.63B
3.13%2.82B
-60.38%2.97B
-64.82%2.5B
-64.08%2.42B
-53.13%2.73B
28.75%7.5B
37.31%7.1B
Transactional financial assets
----
----
----
----
----
----
--5.81K
-28.39%16.41K
-30.84%10.12K
65,701.08%8.8M
Notes receivable and accounts receivable
24.41%947.26M
18.42%968.48M
-3.82%750.01M
-2.47%758.89M
7.46%761.39M
23.12%817.86M
18.67%779.8M
18.04%778.09M
14.86%708.53M
20.83%664.31M
-Notes receivable
17.42%58.18M
-22.79%56.73M
31.58%52.94M
33.07%59.34M
50.37%49.55M
41.19%73.48M
18.71%40.24M
66.14%44.59M
38.28%32.95M
29.17%52.04M
-Accounts receivable
24.90%889.08M
22.48%911.75M
-5.75%697.07M
-4.63%699.55M
5.37%711.85M
21.58%744.38M
18.67%739.57M
16.00%733.5M
13.92%675.58M
20.17%612.26M
Other receivables (including interest and dividends)
-34.77%65.49M
-45.45%56.66M
-35.42%87.48M
-30.55%93.68M
-19.17%100.4M
-12.62%103.86M
48.75%135.46M
61.06%134.89M
64.82%124.22M
69.55%118.87M
-Dividend receivable
----
----
-9.09%12M
38.30%18.4M
----
----
--13.2M
90.52%13.3M
----
----
-Other receivable
----
----
----
-38.08%75.28M
----
-12.62%103.86M
----
58.38%121.58M
----
69.55%118.87M
Advance payment
126.52%353.39M
1.57%340.43M
-30.63%184.49M
89.75%382.29M
45.89%156.01M
74.56%335.18M
40.57%265.94M
47.94%201.47M
-38.43%106.94M
16.43%192.02M
Inventories
43.23%3.88B
28.57%3.38B
18.46%2.78B
10.55%2.56B
8.47%2.71B
7.81%2.63B
5.66%2.35B
5.17%2.31B
21.09%2.5B
11.25%2.44B
Receivable financing
11.98%125.29M
26.75%52.77M
21.67%66M
173.33%102.28M
635.62%111.89M
362.75%41.63M
1.61%54.24M
48.03%37.42M
-75.01%15.21M
-63.39%9M
Other current assets
35.50%8.58B
45.56%9.14B
33.71%7.63B
32.18%7.28B
6,418.86%6.33B
5,820.82%6.28B
5,709.04%5.71B
5,970.82%5.51B
-6.13%97.1M
-15.77%106.1M
Total current assets
24.24%16.32B
18.85%15.1B
20.73%14.13B
19.54%13.99B
18.94%13.14B
19.48%12.7B
16.62%11.71B
29.76%11.7B
23.90%11.05B
28.19%10.63B
Non Current assets
Other equity investment
-9.05%356.21M
0.38%377.1M
13.20%404.19M
3.01%387.33M
-1.34%391.66M
-20.18%375.68M
-24.16%357.07M
-20.18%376.03M
-9.93%396.99M
7.62%470.66M
Other non-current financial assets
-7.88%46.17M
14.41%61.32M
-44.83%33.7M
-45.41%33.7M
-18.54%50.12M
-13.12%53.6M
-2.05%61.08M
5.57%61.73M
-6.69%61.53M
1.71%61.69M
Investment real estate
-27.09%11.99M
-41.03%13.64M
-36.83%14.42M
-37.19%15.13M
-30.37%16.44M
-12.48%23.13M
-16.11%22.83M
-23.48%24.09M
-15.09%23.61M
-7.91%26.43M
Long-term equity investment
-20.99%194.87M
-20.81%193.55M
-6.36%225.7M
-10.36%222.71M
-12.27%246.65M
-8.64%244.42M
-29.76%241.04M
-26.59%248.46M
-41.62%281.15M
-44.40%267.53M
Fixed assets
----
----
----
0.28%261.87M
----
-1.17%260.89M
----
1.85%261.14M
----
1.25%263.98M
Fixed assets liquidation
----
----
----
-96.73%1.29K
----
-98.37%1.24K
----
--39.5K
----
--76.04K
Constru in process
----
----
----
161.79%106.07M
----
306.79%60.78M
----
1,428.99%40.52M
----
1,356.43%14.94M
Productive biological assets
4.09%12.27M
5.44%12.22M
-5.95%12.22M
-6.31%11.99M
-5.53%11.78M
-6.69%11.59M
-1.84%13M
-6.21%12.79M
-6.57%12.47M
-5.97%12.42M
Intangible assets
-7.10%288.4M
-8.86%291.09M
8.38%308.94M
6.54%309.32M
47.14%310.45M
44.54%319.37M
20.61%285.06M
20.91%290.32M
-7.63%210.99M
-14.81%220.96M
Long deferred expense
-28.73%27.5M
-20.35%29.99M
4.92%38.54M
10.70%44.49M
-0.97%38.58M
-14.78%37.65M
-22.92%36.73M
-14.20%40.2M
-22.05%38.96M
-10.59%44.19M
Deferred tax assets
13.36%201.51M
11.99%187.31M
51.60%188.71M
36.73%178.71M
12.34%177.76M
0.17%167.26M
-2.34%124.48M
23.37%130.71M
31.68%158.24M
95.51%166.98M
Usufruct assets
5.89%135.97M
0.08%132.47M
-5.27%119.62M
-0.11%125.42M
22.24%128.41M
21.66%132.36M
12.80%126.28M
6.75%125.56M
-7.79%105.05M
-15.71%108.79M
Other non current assets
1.77%217.26M
-0.26%211.72M
-5.24%215.72M
-4.66%218.36M
-15.33%213.49M
-7.34%212.28M
1.22%227.64M
-2.86%229.03M
7.93%252.14M
-1.45%229.09M
Adjustment items of non current assets
----
----
----
----
----
----
----
---0.01
----
----
Total non current assets
2.18%1.97B
4.29%1.98B
8.57%1.96B
4.05%1.92B
5.59%1.93B
0.60%1.9B
-6.86%1.81B
-4.06%1.84B
-10.51%1.83B
-7.40%1.89B
Total assets
21.41%18.29B
16.96%17.08B
19.10%16.1B
17.44%15.91B
17.05%15.07B
16.63%14.6B
12.82%13.51B
23.83%13.55B
17.49%12.87B
21.17%12.52B
Liabilities
Current liabilities
Short term loan
19.48%1.08B
1.95%989.93M
1.45%813.87M
12.41%892.72M
26.48%904.03M
25.16%970.96M
15.90%802.22M
14.99%794.14M
6.10%714.75M
7.99%775.79M
Notes payable and accounts payable
83.97%767.54M
44.29%673.15M
8.49%435.85M
25.57%458.19M
41.18%417.22M
20.34%466.52M
25.26%401.74M
29.42%364.9M
-4.10%295.52M
61.03%387.66M
-Notes payable
73.60%197.45M
61.47%167.29M
-3.45%74.03M
92.60%108.06M
82.05%113.74M
58.90%103.6M
13.93%76.67M
1,218.18%56.11M
468.99%62.48M
252.07%65.2M
-Accounts payable
87.85%570.09M
39.39%505.86M
11.31%361.82M
13.39%350.13M
30.22%303.48M
12.55%362.92M
28.27%325.06M
11.20%308.79M
-21.58%233.05M
45.11%322.46M
Contract liabilities
-32.68%81.27M
-49.40%237.1M
7.59%85.15M
57.76%124.56M
3.59%120.72M
43.49%468.57M
31.80%79.14M
-29.22%78.95M
17.09%116.53M
15.09%326.56M
Advance receipts
44.78%11.96M
-61.97%3.58M
17.58%15.6M
-64.83%3.03M
-15.55%8.26M
57.81%9.42M
-61.51%13.26M
-20.99%8.62M
-9.99%9.79M
81.81%5.97M
Salaries payable
4.53%140.41M
13.35%150.15M
77.62%160.77M
2.88%130.46M
21.09%134.33M
30.07%132.46M
-23.01%90.51M
12.90%126.81M
45.49%110.93M
15.93%101.84M
Taxs payable
48.84%315.81M
60.41%172.98M
40.36%298.27M
52.13%236.27M
-10.35%212.17M
-20.75%107.83M
-30.33%212.5M
-16.68%155.32M
-13.69%236.68M
1.64%136.08M
Other payable (including interest and dividends)
99.18%664.5M
120.06%595.47M
42.14%418.76M
-0.67%1.08B
-11.64%333.62M
-22.38%270.6M
-25.34%294.62M
166.56%1.09B
-4.34%377.58M
15.72%348.64M
-Dividend payable
7.31%7.45M
9.93%7.63M
0.00%5.86M
3.28%760.01M
18.41%6.94M
18.41%6.94M
0.00%5.86M
12,449.12%735.88M
0.00%5.86M
0.00%5.86M
-Other payable
----
----
----
-8.90%321.53M
----
-23.08%263.66M
----
-12.34%352.95M
----
16.03%342.78M
Non current liabilities due within one year
0.71%29.76M
15.46%33.73M
36.58%28.01M
33.59%29.79M
70.94%29.55M
28.38%29.21M
--20.51M
--22.3M
--17.28M
-2.94%22.75M
Other current liabilities
-10.45%6.78M
-50.51%27.02M
-1.00%6.31M
109.84%14.01M
83.79%7.57M
71.75%54.59M
-52.68%6.38M
-38.99%6.68M
-38.67%4.12M
9.38%31.79M
Total current liabilities
42.94%3.1B
14.86%2.88B
17.79%2.26B
12.24%2.97B
15.10%2.17B
17.46%2.51B
-0.88%1.92B
45.96%2.65B
2.12%1.88B
17.31%2.14B
Current liabilities
Long term loan
--48.08M
--35.44M
--29.58M
--19.29M
----
----
----
----
----
----
Long term salaries pay
-0.46%34.59M
2.20%35.04M
7.21%34.54M
6.41%34.94M
6.52%34.75M
6.37%34.29M
12.11%32.22M
12.89%32.84M
12.78%32.62M
9.54%32.23M
Estimate liabilities
--6.61M
--12M
----
----
----
----
----
----
----
----
Deferred tax liabilities
-56.81%29.03M
-50.86%30.02M
172.28%56.24M
73.96%49.38M
61.17%67.22M
-18.02%61.09M
-57.92%20.66M
-37.19%28.38M
-10.72%41.7M
56.98%74.52M
Long term deferred income
10.88%18.41M
3.87%17.67M
-9.40%17.09M
-10.65%17.65M
-17.88%16.6M
-15.97%17.01M
-23.01%18.86M
23.91%19.75M
28.13%20.22M
37.89%20.24M
Lease liabilities
10.51%114.5M
-1.39%107.29M
-11.90%97.05M
-6.20%98.71M
18.41%103.61M
25.53%108.8M
-1.30%110.16M
-8.66%105.23M
-21.26%87.5M
-18.60%86.67M
Other non current liabilities
-17.02%38.91M
-18.94%39.35M
26.57%39.18M
80.78%48.57M
56.58%46.89M
47.63%48.54M
-1.46%30.96M
-23.32%26.87M
-45.56%29.95M
-42.41%32.88M
Total non current liabilities
7.83%290.14M
2.63%276.81M
28.58%273.68M
26.03%268.53M
26.93%269.07M
9.40%269.72M
-13.25%212.85M
-11.39%213.07M
-17.69%211.99M
-3.37%246.54M
Total liabilities
39.06%3.39B
13.67%3.16B
18.87%2.54B
13.27%3.24B
16.29%2.44B
16.63%2.78B
-2.27%2.13B
39.25%2.86B
-0.31%2.1B
14.77%2.38B
Shareholders equity
Paid-in capital
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
Capital reserve funds
0.08%1.09B
0.09%1.09B
-0.12%1.09B
-0.12%1.09B
0.73%1.09B
0.72%1.09B
0.90%1.1B
0.89%1.1B
0.03%1.09B
0.03%1.09B
Surplus reserve funds
18.68%1.61B
18.68%1.61B
21.17%1.35B
21.17%1.35B
21.17%1.35B
21.17%1.35B
26.17%1.12B
26.17%1.12B
26.17%1.12B
26.17%1.12B
Retained profit
22.23%10.97B
21.82%10B
22.87%9.86B
23.46%8.99B
21.48%8.98B
22.48%8.21B
22.21%8.02B
28.51%7.28B
33.32%7.39B
34.62%6.7B
Other composite income
-32.18%58.85M
2.95%76.6M
67.64%100.29M
-29.02%86.45M
-36.49%86.77M
-62.81%74.41M
-70.99%59.83M
-41.03%121.8M
-56.42%136.62M
-35.79%200.05M
Shareholders equity without minority interests
18.34%14.33B
18.06%13.38B
19.36%13.01B
18.67%12.13B
17.24%12.11B
16.74%11.33B
16.62%10.9B
20.98%10.22B
22.56%10.33B
23.45%9.71B
Minority interests
10.30%572.94M
10.16%544.17M
14.34%551.92M
15.94%538.44M
16.11%519.44M
14.33%493.97M
7.17%482.71M
6.47%464.4M
4.92%447.36M
9.56%432.07M
Total shareholder equity
18.01%14.91B
17.73%13.92B
19.15%13.56B
18.55%12.67B
17.19%12.63B
16.64%11.82B
16.18%11.38B
20.27%10.69B
21.71%10.78B
22.78%10.14B
Total liabilityies and equity
21.41%18.29B
16.96%17.08B
19.10%16.1B
17.44%15.91B
17.05%15.07B
16.63%14.6B
12.82%13.51B
23.83%13.55B
17.49%12.87B
21.17%12.52B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -20.05%2.37B-53.58%1.16B8.98%2.63B3.13%2.82B-60.38%2.97B-64.82%2.5B-64.08%2.42B-53.13%2.73B28.75%7.5B37.31%7.1B
Transactional financial assets --------------------------5.81K-28.39%16.41K-30.84%10.12K65,701.08%8.8M
Notes receivable and accounts receivable 24.41%947.26M18.42%968.48M-3.82%750.01M-2.47%758.89M7.46%761.39M23.12%817.86M18.67%779.8M18.04%778.09M14.86%708.53M20.83%664.31M
-Notes receivable 17.42%58.18M-22.79%56.73M31.58%52.94M33.07%59.34M50.37%49.55M41.19%73.48M18.71%40.24M66.14%44.59M38.28%32.95M29.17%52.04M
-Accounts receivable 24.90%889.08M22.48%911.75M-5.75%697.07M-4.63%699.55M5.37%711.85M21.58%744.38M18.67%739.57M16.00%733.5M13.92%675.58M20.17%612.26M
Other receivables (including interest and dividends) -34.77%65.49M-45.45%56.66M-35.42%87.48M-30.55%93.68M-19.17%100.4M-12.62%103.86M48.75%135.46M61.06%134.89M64.82%124.22M69.55%118.87M
-Dividend receivable ---------9.09%12M38.30%18.4M----------13.2M90.52%13.3M--------
-Other receivable -------------38.08%75.28M-----12.62%103.86M----58.38%121.58M----69.55%118.87M
Advance payment 126.52%353.39M1.57%340.43M-30.63%184.49M89.75%382.29M45.89%156.01M74.56%335.18M40.57%265.94M47.94%201.47M-38.43%106.94M16.43%192.02M
Inventories 43.23%3.88B28.57%3.38B18.46%2.78B10.55%2.56B8.47%2.71B7.81%2.63B5.66%2.35B5.17%2.31B21.09%2.5B11.25%2.44B
Receivable financing 11.98%125.29M26.75%52.77M21.67%66M173.33%102.28M635.62%111.89M362.75%41.63M1.61%54.24M48.03%37.42M-75.01%15.21M-63.39%9M
Other current assets 35.50%8.58B45.56%9.14B33.71%7.63B32.18%7.28B6,418.86%6.33B5,820.82%6.28B5,709.04%5.71B5,970.82%5.51B-6.13%97.1M-15.77%106.1M
Total current assets 24.24%16.32B18.85%15.1B20.73%14.13B19.54%13.99B18.94%13.14B19.48%12.7B16.62%11.71B29.76%11.7B23.90%11.05B28.19%10.63B
Non Current assets
Other equity investment -9.05%356.21M0.38%377.1M13.20%404.19M3.01%387.33M-1.34%391.66M-20.18%375.68M-24.16%357.07M-20.18%376.03M-9.93%396.99M7.62%470.66M
Other non-current financial assets -7.88%46.17M14.41%61.32M-44.83%33.7M-45.41%33.7M-18.54%50.12M-13.12%53.6M-2.05%61.08M5.57%61.73M-6.69%61.53M1.71%61.69M
Investment real estate -27.09%11.99M-41.03%13.64M-36.83%14.42M-37.19%15.13M-30.37%16.44M-12.48%23.13M-16.11%22.83M-23.48%24.09M-15.09%23.61M-7.91%26.43M
Long-term equity investment -20.99%194.87M-20.81%193.55M-6.36%225.7M-10.36%222.71M-12.27%246.65M-8.64%244.42M-29.76%241.04M-26.59%248.46M-41.62%281.15M-44.40%267.53M
Fixed assets ------------0.28%261.87M-----1.17%260.89M----1.85%261.14M----1.25%263.98M
Fixed assets liquidation -------------96.73%1.29K-----98.37%1.24K------39.5K------76.04K
Constru in process ------------161.79%106.07M----306.79%60.78M----1,428.99%40.52M----1,356.43%14.94M
Productive biological assets 4.09%12.27M5.44%12.22M-5.95%12.22M-6.31%11.99M-5.53%11.78M-6.69%11.59M-1.84%13M-6.21%12.79M-6.57%12.47M-5.97%12.42M
Intangible assets -7.10%288.4M-8.86%291.09M8.38%308.94M6.54%309.32M47.14%310.45M44.54%319.37M20.61%285.06M20.91%290.32M-7.63%210.99M-14.81%220.96M
Long deferred expense -28.73%27.5M-20.35%29.99M4.92%38.54M10.70%44.49M-0.97%38.58M-14.78%37.65M-22.92%36.73M-14.20%40.2M-22.05%38.96M-10.59%44.19M
Deferred tax assets 13.36%201.51M11.99%187.31M51.60%188.71M36.73%178.71M12.34%177.76M0.17%167.26M-2.34%124.48M23.37%130.71M31.68%158.24M95.51%166.98M
Usufruct assets 5.89%135.97M0.08%132.47M-5.27%119.62M-0.11%125.42M22.24%128.41M21.66%132.36M12.80%126.28M6.75%125.56M-7.79%105.05M-15.71%108.79M
Other non current assets 1.77%217.26M-0.26%211.72M-5.24%215.72M-4.66%218.36M-15.33%213.49M-7.34%212.28M1.22%227.64M-2.86%229.03M7.93%252.14M-1.45%229.09M
Adjustment items of non current assets -------------------------------0.01--------
Total non current assets 2.18%1.97B4.29%1.98B8.57%1.96B4.05%1.92B5.59%1.93B0.60%1.9B-6.86%1.81B-4.06%1.84B-10.51%1.83B-7.40%1.89B
Total assets 21.41%18.29B16.96%17.08B19.10%16.1B17.44%15.91B17.05%15.07B16.63%14.6B12.82%13.51B23.83%13.55B17.49%12.87B21.17%12.52B
Liabilities
Current liabilities
Short term loan 19.48%1.08B1.95%989.93M1.45%813.87M12.41%892.72M26.48%904.03M25.16%970.96M15.90%802.22M14.99%794.14M6.10%714.75M7.99%775.79M
Notes payable and accounts payable 83.97%767.54M44.29%673.15M8.49%435.85M25.57%458.19M41.18%417.22M20.34%466.52M25.26%401.74M29.42%364.9M-4.10%295.52M61.03%387.66M
-Notes payable 73.60%197.45M61.47%167.29M-3.45%74.03M92.60%108.06M82.05%113.74M58.90%103.6M13.93%76.67M1,218.18%56.11M468.99%62.48M252.07%65.2M
-Accounts payable 87.85%570.09M39.39%505.86M11.31%361.82M13.39%350.13M30.22%303.48M12.55%362.92M28.27%325.06M11.20%308.79M-21.58%233.05M45.11%322.46M
Contract liabilities -32.68%81.27M-49.40%237.1M7.59%85.15M57.76%124.56M3.59%120.72M43.49%468.57M31.80%79.14M-29.22%78.95M17.09%116.53M15.09%326.56M
Advance receipts 44.78%11.96M-61.97%3.58M17.58%15.6M-64.83%3.03M-15.55%8.26M57.81%9.42M-61.51%13.26M-20.99%8.62M-9.99%9.79M81.81%5.97M
Salaries payable 4.53%140.41M13.35%150.15M77.62%160.77M2.88%130.46M21.09%134.33M30.07%132.46M-23.01%90.51M12.90%126.81M45.49%110.93M15.93%101.84M
Taxs payable 48.84%315.81M60.41%172.98M40.36%298.27M52.13%236.27M-10.35%212.17M-20.75%107.83M-30.33%212.5M-16.68%155.32M-13.69%236.68M1.64%136.08M
Other payable (including interest and dividends) 99.18%664.5M120.06%595.47M42.14%418.76M-0.67%1.08B-11.64%333.62M-22.38%270.6M-25.34%294.62M166.56%1.09B-4.34%377.58M15.72%348.64M
-Dividend payable 7.31%7.45M9.93%7.63M0.00%5.86M3.28%760.01M18.41%6.94M18.41%6.94M0.00%5.86M12,449.12%735.88M0.00%5.86M0.00%5.86M
-Other payable -------------8.90%321.53M-----23.08%263.66M-----12.34%352.95M----16.03%342.78M
Non current liabilities due within one year 0.71%29.76M15.46%33.73M36.58%28.01M33.59%29.79M70.94%29.55M28.38%29.21M--20.51M--22.3M--17.28M-2.94%22.75M
Other current liabilities -10.45%6.78M-50.51%27.02M-1.00%6.31M109.84%14.01M83.79%7.57M71.75%54.59M-52.68%6.38M-38.99%6.68M-38.67%4.12M9.38%31.79M
Total current liabilities 42.94%3.1B14.86%2.88B17.79%2.26B12.24%2.97B15.10%2.17B17.46%2.51B-0.88%1.92B45.96%2.65B2.12%1.88B17.31%2.14B
Current liabilities
Long term loan --48.08M--35.44M--29.58M--19.29M------------------------
Long term salaries pay -0.46%34.59M2.20%35.04M7.21%34.54M6.41%34.94M6.52%34.75M6.37%34.29M12.11%32.22M12.89%32.84M12.78%32.62M9.54%32.23M
Estimate liabilities --6.61M--12M--------------------------------
Deferred tax liabilities -56.81%29.03M-50.86%30.02M172.28%56.24M73.96%49.38M61.17%67.22M-18.02%61.09M-57.92%20.66M-37.19%28.38M-10.72%41.7M56.98%74.52M
Long term deferred income 10.88%18.41M3.87%17.67M-9.40%17.09M-10.65%17.65M-17.88%16.6M-15.97%17.01M-23.01%18.86M23.91%19.75M28.13%20.22M37.89%20.24M
Lease liabilities 10.51%114.5M-1.39%107.29M-11.90%97.05M-6.20%98.71M18.41%103.61M25.53%108.8M-1.30%110.16M-8.66%105.23M-21.26%87.5M-18.60%86.67M
Other non current liabilities -17.02%38.91M-18.94%39.35M26.57%39.18M80.78%48.57M56.58%46.89M47.63%48.54M-1.46%30.96M-23.32%26.87M-45.56%29.95M-42.41%32.88M
Total non current liabilities 7.83%290.14M2.63%276.81M28.58%273.68M26.03%268.53M26.93%269.07M9.40%269.72M-13.25%212.85M-11.39%213.07M-17.69%211.99M-3.37%246.54M
Total liabilities 39.06%3.39B13.67%3.16B18.87%2.54B13.27%3.24B16.29%2.44B16.63%2.78B-2.27%2.13B39.25%2.86B-0.31%2.1B14.77%2.38B
Shareholders equity
Paid-in capital 0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M
Capital reserve funds 0.08%1.09B0.09%1.09B-0.12%1.09B-0.12%1.09B0.73%1.09B0.72%1.09B0.90%1.1B0.89%1.1B0.03%1.09B0.03%1.09B
Surplus reserve funds 18.68%1.61B18.68%1.61B21.17%1.35B21.17%1.35B21.17%1.35B21.17%1.35B26.17%1.12B26.17%1.12B26.17%1.12B26.17%1.12B
Retained profit 22.23%10.97B21.82%10B22.87%9.86B23.46%8.99B21.48%8.98B22.48%8.21B22.21%8.02B28.51%7.28B33.32%7.39B34.62%6.7B
Other composite income -32.18%58.85M2.95%76.6M67.64%100.29M-29.02%86.45M-36.49%86.77M-62.81%74.41M-70.99%59.83M-41.03%121.8M-56.42%136.62M-35.79%200.05M
Shareholders equity without minority interests 18.34%14.33B18.06%13.38B19.36%13.01B18.67%12.13B17.24%12.11B16.74%11.33B16.62%10.9B20.98%10.22B22.56%10.33B23.45%9.71B
Minority interests 10.30%572.94M10.16%544.17M14.34%551.92M15.94%538.44M16.11%519.44M14.33%493.97M7.17%482.71M6.47%464.4M4.92%447.36M9.56%432.07M
Total shareholder equity 18.01%14.91B17.73%13.92B19.15%13.56B18.55%12.67B17.19%12.63B16.64%11.82B16.18%11.38B20.27%10.69B21.71%10.78B22.78%10.14B
Total liabilityies and equity 21.41%18.29B16.96%17.08B19.10%16.1B17.44%15.91B17.05%15.07B16.63%14.6B12.82%13.51B23.83%13.55B17.49%12.87B21.17%12.52B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg